Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Morepen Laboratories Limited ( (IN:MOREPENLAB) ) just unveiled an announcement.
Morepen Laboratories has reported to the stock exchanges on the status of shareholder requests for re-lodgement of physical share transfer requests under a special six-month window mandated by the Securities and Exchange Board of India (SEBI). For the period from 1 January 2026 to 6 January 2026, the company’s registrar and share transfer agent, MAS Services Limited, confirmed that one request for re-lodgement of physical share transfer was received and processed, with the request being rejected and no approvals granted, indicating minimal activity and a limited operational impact from the SEBI special window during this initial period.
More about Morepen Laboratories Limited
Morepen Laboratories Limited is an Indian pharmaceutical company engaged in the manufacture and marketing of bulk drugs, formulations, diagnostics and healthcare products, serving domestic and international markets from its facilities in Himachal Pradesh and corporate office in Gurugram.
Average Trading Volume: 104,695
Technical Sentiment Signal: Sell
Current Market Cap: 18.73B INR
Find detailed analytics on MOREPENLAB stock on TipRanks’ Stock Analysis page.